News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
148,116 Results
Type
Article (3089)
Company Profile (108)
Press Release (144919)
Section
Business (47486)
Career Advice (88)
Deals (8426)
Drug Delivery (3)
Drug Development (29313)
Employer Resources (12)
FDA (2376)
Job Trends (3207)
News (86377)
Policy (5619)
Tag
Academia (142)
Allergies (17)
Alliances (10566)
Alzheimer's disease (253)
Approvals (2370)
Bankruptcy (48)
Best Places to Work (2799)
Biotechnology (74)
Breast cancer (15)
Cancer (268)
Career advice (80)
Cell therapy (43)
Clinical research (24640)
Collaboration (75)
Compensation (99)
COVID-19 (345)
C-suite (33)
Data (359)
Diabetes (36)
Diagnostics (298)
Earnings (20740)
Events (30209)
Executive appointments (102)
FDA (2504)
Featured Employer (24)
Funding (62)
GLP-1 (112)
Government (373)
Healthcare (1670)
Infectious disease (359)
Inflammatory bowel disease (31)
IPO (5177)
Job creations (508)
Job search strategy (75)
Layoffs (30)
Legal (692)
Lung cancer (50)
Manufacturing (38)
MASH (15)
Medical device (288)
Medtech (288)
Mergers & acquisitions (3326)
Metabolic disorders (94)
Neuroscience (317)
NextGen Class of 2024 (696)
Non-profit (176)
Northern California (523)
Obesity (42)
Patents (18)
People (14630)
Pharmaceutical (34)
Phase I (7223)
Phase II (11230)
Phase III (8107)
Pipeline (170)
Postmarket research (478)
Preclinical (2635)
Radiopharmaceuticals (90)
Rare diseases (39)
Real estate (930)
Regulatory (4796)
Research institute (182)
Schizophrenia (21)
Southern California (443)
Startups (713)
United States (4083)
Vaccines (61)
Date
Today (83)
Last 7 days (333)
Last 30 days (1124)
Last 365 days (10865)
2024 (9757)
2023 (12367)
2022 (14237)
2021 (16004)
2020 (13727)
2019 (8837)
2018 (6248)
2017 (8072)
2016 (6574)
2015 (8393)
2014 (6322)
2013 (4517)
2012 (4446)
2011 (4448)
2010 (4453)
Location
Africa (78)
Arizona (15)
Asia (11342)
Australia (1240)
California (1093)
Canada (296)
China (115)
Colorado (30)
Connecticut (40)
Delaware (30)
Europe (20924)
Florida (114)
Georgia (32)
Illinois (43)
Indiana (30)
Japan (16)
Kansas (45)
Maryland (129)
Massachusetts (923)
Michigan (27)
Minnesota (46)
New Jersey (402)
New York (416)
North Carolina (240)
Northern California (523)
Ohio (36)
Pennsylvania (224)
South America (122)
Southern California (443)
Texas (104)
Utah (18)
Virginia (20)
Washington State (61)
148,116 Results for "oxeia biopharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
OXEIA BIOPHARMACEUTICALS ANNOUNCES NEW BOARD AND MANAGEMENT TEAM MEMBERS AND RELOCATES CORPORATE HEADQUARTERS TO BOSTON
Oxeia Biopharmaceuticals today announced two new board members and additions to its executive leadership team.
January 20, 2022
·
5 min read
Drug Development
OXEIA ANNOUNCES POSITIVE INTERIM RESULTS OF PHASE 2 TRIAL FOR OXE103 FOR THE TREATMENT OF CONCUSSIONS
Oxeia Biopharmaceuticals Inc., a clinical stage biotech company developing a drug treatment for concussion to address underlying neuro-metabolic dysfunction and axonal injury, announced today the completion of an interim analysis of its ongoing Phase 2 clinical trial of OXE103 at the University of Kansas Medical Center.
August 3, 2022
·
3 min read
Press Releases
Biopharmaceuticals Market to Hit US$ 654.76 Billion by 2030, Coherent Market Insights
November 13, 2024
·
1 min read
Press Releases
Biopharmaceutical Market Size to Reach USD 643.9 Billion by 2032, Impelled by Advancements in Biotechnology
Biopharmaceutical Market Outlook 2024-2032:
August 1, 2024
·
9 min read
Press Releases
Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
October 10, 2024
·
3 min read
Press Releases
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
October 25, 2024
·
3 min read
BioMidwest
Provectus Biopharmaceuticals Announces Investor Webinar for 2024 Annual Meeting of Stockholders
Provectus Biopharmaceuticals, Inc. announced that its 2024 annual stockholder meeting, including meeting activities and a company update, will be accessible by Zoom Webinar.
June 13, 2024
·
5 min read
Press Releases
U.S. Biopharmaceutical Third-party Logistics Market Size to Surpass USD 99.75 Bn by 2033
November 5, 2024
·
1 min read
Press Releases
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
November 5, 2024
·
4 min read
Press Releases
Angitia Biopharmaceuticals to Present Data on AGA2118 for Osteoporosis at ASBMR 2024
September 16, 2024
·
4 min read
1 of 14,812
Next
